SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-023753
Filing Date
2023-05-24
Accepted
2023-05-24 06:59:40
Documents
17
Period of Report
2023-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pyxs-20230523.htm   iXBRL 8-K 96853
2 EX-2.1 pyxs-ex2_1.htm EX-2.1 1332120
3 EX-10.1 pyxs-ex10_1.htm EX-10.1 84085
4 EX-99.1 pyxs-ex99_1.htm EX-99.1 71379
5 GRAPHIC img244827169_0.jpg GRAPHIC 6256
6 GRAPHIC img244827169_1.jpg GRAPHIC 13808
  Complete submission text file 0000950170-23-023753.txt   1908420

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pyxs-20230523_lab.xml EX-101.LAB 14018
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pyxs-20230523_pre.xml EX-101.PRE 10289
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pyxs-20230523.xsd EX-101.SCH 2472
11 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20230523_htm.xml XML 4910
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40881 | Film No.: 23950557
SIC: 2834 Pharmaceutical Preparations